Full Text View
Tabular View
No Study Results Posted
Related Studies
BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
This study is currently recruiting participants.
Verified November 2014 by Hoffmann-La Roche
Study NCT01519323   Information provided by Hoffmann-La Roche

First Received on January 16, 2012.   Last Updated on November 24, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial